Eli Lilly signs deal with U.S. for 300,000 vials of potential COVID-19 drug
28 Oct 2020 / 18:51 H.
Oct 28 (Reuters) - Eli Lilly and Co said on Wednesday it signed an agreement with the U.S. government to supply 300,000 vials of its experimental antibody drug to treat COVID-19 for $375 million. (Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)
Did you like this article?
